CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 298 enrolled
Drug / intervention
Escitalopram +3 moredrug
Likely dose
Escitalopram 20mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00146900
NCT00146900N/ACompleted

Prevention of Post Traumatic Stress Disorder by Early Treatment

Hadassah Medical Organization·interventional·Posted Sep 7, 2005·Updated Feb 19, 2016

In Brief

A clinical study evaluating Cognitive Behavioral Therapy, Cognitive Therapy, and 2 other interventions for Post-traumatic Stress Disorder. Completed, enrolled 298 participants across 1 site.

Detailed Summary

To prospectively evaluate the effect of early treatment (cognitive therapy (CT), cognitive-behavioral therapy (CBT) and escitalopram (SSRI) in preventing the occurrence of post-traumatic stress disorder in recent survivors of traumatic events.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesIsrael
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 7, 2005
Enrollment StartAug 1, 2004
Primary CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 20.8 years ago

Interventions

Cognitive Behavioral Therapyprocedure

12 weekly 1.5 hours weekly session of cognitive behavioral therapy (Prolonged Exposure)

Cognitive Therapyprocedure

12 weekly 1.5 hours weekly session of cognitive therapy without exposure

Escitalopramdrug

Twelve weeks of treatment with Escitalopram at Max. daily dose of 20mg

Placeboother

Twelve weeks of treatment with placebo pills resembling the original Escitalopram 10mg tablets but containing no active substance